At a glance
- Originator Eli Lilly and Company
- Class Antivirals; Purine nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cytomegalovirus infections; Hepatitis B
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)
- 06 Jun 2001 No-Development-Reported for Hepatitis B in USA (Unknown route)
- 20 Jan 1995 Preclinical development for Cytomegalovirus infections in USA (Unknown route)